MA46634A - Composition pour le traitement préventif ou curatif de troubles hépatiques - Google Patents
Composition pour le traitement préventif ou curatif de troubles hépatiquesInfo
- Publication number
- MA46634A MA46634A MA046634A MA46634A MA46634A MA 46634 A MA46634 A MA 46634A MA 046634 A MA046634 A MA 046634A MA 46634 A MA46634 A MA 46634A MA 46634 A MA46634 A MA 46634A
- Authority
- MA
- Morocco
- Prior art keywords
- preventive
- composition
- curative treatment
- hepatic disorders
- hepatic
- Prior art date
Links
- 238000009109 curative therapy Methods 0.000 title 1
- 230000002440 hepatic effect Effects 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102016000109507A IT201600109507A1 (it) | 2016-10-28 | 2016-10-28 | Composizione per il trattamento preventivo o curativo dei disturbi epatici |
Publications (1)
Publication Number | Publication Date |
---|---|
MA46634A true MA46634A (fr) | 2021-04-28 |
Family
ID=58228400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA046634A MA46634A (fr) | 2016-10-28 | 2017-10-30 | Composition pour le traitement préventif ou curatif de troubles hépatiques |
Country Status (12)
Country | Link |
---|---|
US (1) | US20190336547A1 (fr) |
EP (1) | EP3532081B1 (fr) |
JP (1) | JP2019534013A (fr) |
KR (1) | KR20190072613A (fr) |
CN (1) | CN110418836A (fr) |
BR (1) | BR112019008370A2 (fr) |
CA (1) | CA3041599A1 (fr) |
ES (1) | ES2963178T3 (fr) |
IT (1) | IT201600109507A1 (fr) |
MA (1) | MA46634A (fr) |
RU (1) | RU2019115476A (fr) |
WO (1) | WO2018078599A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021020920A2 (fr) * | 2019-07-30 | 2021-02-04 | 주식회사 고바이오랩 | Kit pour prédire ou diagnostiquer une stéatose hépatique non alcoolique et procédé pour diagnostiquer une stéatose hépatique |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132710A (en) * | 1997-03-17 | 2000-10-17 | Probiotix, Inc. | Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof |
US20020013270A1 (en) * | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
JP5592439B2 (ja) * | 2012-06-13 | 2014-09-17 | 雪印メグミルク株式会社 | 加齢に伴う代謝異常疾患の予防・改善・治療剤 |
KR101545551B1 (ko) * | 2013-12-12 | 2015-08-19 | 주식회사한국야쿠르트 | 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물 |
AU2015258769A1 (en) * | 2014-05-12 | 2016-12-01 | Medlab Ip Pty Ltd | Probiotic compositions and uses thereof for treatment of obesity-related disorders |
WO2016070151A1 (fr) * | 2014-10-31 | 2016-05-06 | Whole Biome. Inc. | Procédés et compositions se rapportant à un traitement microbien et au diagnostic de troubles |
-
2016
- 2016-10-28 IT IT102016000109507A patent/IT201600109507A1/it unknown
-
2017
- 2017-10-30 JP JP2019522957A patent/JP2019534013A/ja active Pending
- 2017-10-30 BR BR112019008370A patent/BR112019008370A2/pt not_active IP Right Cessation
- 2017-10-30 ES ES17804944T patent/ES2963178T3/es active Active
- 2017-10-30 RU RU2019115476A patent/RU2019115476A/ru not_active Application Discontinuation
- 2017-10-30 EP EP17804944.1A patent/EP3532081B1/fr active Active
- 2017-10-30 CN CN201780066839.7A patent/CN110418836A/zh active Pending
- 2017-10-30 WO PCT/IB2017/056728 patent/WO2018078599A2/fr unknown
- 2017-10-30 US US16/345,680 patent/US20190336547A1/en not_active Abandoned
- 2017-10-30 CA CA3041599A patent/CA3041599A1/fr not_active Abandoned
- 2017-10-30 KR KR1020197014838A patent/KR20190072613A/ko not_active Application Discontinuation
- 2017-10-30 MA MA046634A patent/MA46634A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018078599A4 (fr) | 2018-08-09 |
EP3532081C0 (fr) | 2023-08-30 |
BR112019008370A2 (pt) | 2019-07-09 |
CA3041599A1 (fr) | 2018-05-03 |
KR20190072613A (ko) | 2019-06-25 |
ES2963178T3 (es) | 2024-03-25 |
EP3532081B1 (fr) | 2023-08-30 |
RU2019115476A (ru) | 2020-11-30 |
CN110418836A (zh) | 2019-11-05 |
WO2018078599A2 (fr) | 2018-05-03 |
US20190336547A1 (en) | 2019-11-07 |
EP3532081A2 (fr) | 2019-09-04 |
WO2018078599A3 (fr) | 2018-06-07 |
IT201600109507A1 (it) | 2018-04-28 |
JP2019534013A (ja) | 2019-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54925A (fr) | Compositions pour le traitement de troubles acido-basiques | |
MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
MA55629A (fr) | Compositions d'anticorps pour le traitement de tumeurs | |
MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
MA47719A (fr) | Esketamine pour le traitement de la dépression | |
MA49279A (fr) | Compositions d'anticorps optimisées pour le traitement de troubles oculaires | |
MA44737A (fr) | Compositions pour le traitement de troubles liés à l'hyperkératose | |
MA51075A (fr) | Procédés et compositions pour traiter des troubles à l'aide de polypeptides de follistatine | |
MA41449A (fr) | Polythérapies pour le traitement de cancers | |
MA42953A (fr) | Composés et compositions pour le traitement de troubles oculaires | |
MA39753A (fr) | Inhibiteurs de diacylglycérol acyltransférase pour le traitement de troubles métaboliques ou analogues | |
FR3032353B1 (fr) | Composition pharmaceutique et dispositif pour le traitement de la douleur | |
FR3011467B1 (fr) | Composes et compositions comprenant de tels composes pour la prevention ou le traitement des dyslipidemies | |
MA47207A (fr) | Composés utiles pour le traitement de troubles du tractus digestif | |
MA46086A (fr) | Schéma posologique pour le traitement de tumeurs solides | |
MA39927A (fr) | Inhibiteurs de glyt1 pour le traitement de troubles hématologiques | |
MA45226A (fr) | Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate | |
GB201610056D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis | |
ZA202002166B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
MA46099A (fr) | Composés pour le traitement de maladies associées à un dysfonctionnement mitochondrial | |
MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
MA42985A (fr) | Traitement de troubles liés à l'acide biliaire | |
MA49140A (fr) | Composés hétéroaromatiques-aniline fusionnés pour le traitement de troubles dermiques | |
GB201610055D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis |